[1] |
WANG Yuanzhen, WEI Hongyan, CHANG Lixian, ZHANG Yingyuan, LIU Chunyun, LIU Li.
Establishment and validation of a risk prediction model for primary liver cancer complicated with pulmonary infection before intervention
[J]. Tianjin Medical Journal, 2024, 52(9): 940-945.
|
[2] |
WANG Xinshuang, AN Yajuan, GUAN Xiuju, LI Jiao, LIU Yue, WEI Liping, QI Xin.
Study of magnesium isoglycyrrhizinate in ameliorating cisplatin induced myocardial injury in rats
[J]. Tianjin Medical Journal, 2024, 52(8): 809-814.
|
[3] |
QIN Hanlin, HU Changlu, ZHAO Yamei, NIU Weina.
Effect and safety of quadruple regimen in preventing multi-day cisplatin-based chemotherapy induced nausea and vomiting
[J]. Tianjin Medical Journal, 2024, 52(8): 835-839.
|
[4] |
WU Jing, FAN Zhijuan, LIU Shuye.
Changes and clinical significance of plasma free amino acid levels in the development of chronic hepatitis B to hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 738-742.
|
[5] |
LIU Xiaoyan, BU Rui, LU Jianfei, DING Yu, ZHANG Xing.
Value of Sonazoid contrast-enhanced ultrasound for preoperatively evaluating pathological grade of hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(6): 658-662.
|
[6] |
GENG Yongzhi, YANG Li, LI Guowei, ZHANG Jintao, CHENG Xiaolei, TAN Liduan.
Study on the improvement effect and mechanism of nobiletin on rats with acute kidney injury
[J]. Tianjin Medical Journal, 2023, 51(5): 498-503.
|
[7] |
WU Qiong, LI Jinyuan, HUANG Wentao, AN Na.
Effects of acacetin on proliferation, apoptosis and migration of hepatocellular carcinoma HepG2 cells and its mechanism
[J]. Tianjin Medical Journal, 2023, 51(3): 235-239.
|
[8] |
TANG Haoyan, PAN Zhenglong, LIU Xiaofang.
Association between single nucleotide polymorphism of TP53 gene and prognosis of primary hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2023, 51(11): 1249-1254.
|
[9] |
YI Wanping, MA Deshou.
High-intensity focused ultrasound enhances cisplatin chemotherapy sensitivity of breast cancer through TRIF-mediated ERK pathway
[J]. Tianjin Medical Journal, 2022, 50(7): 698-706.
|
[10] |
LYU Kangning, , WANG Lei, QIN Song, WANG Li△.
Research progress of the protective effect and mechanism of C-phycocyanin on liver injury
[J]. Tianjin Medical Journal, 2022, 50(6): 668-672.
|
[11] |
TAN Yuying, ZHANG Weiqi, XIE Yan, LI Jiang, LI Junjie, JIANG Wentao△.
The risk factor analysis and predictive model construction of microvascular invasion in hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2022, 50(5): 523-527.
|
[12] |
MA Zhi, WANG Xinshuang, LIU Yue, WEI Liping, QI Xin.
The protective mechanism of differential isomers of glycyrrhetinic acid on cisplatin-induced H9c2 cardiomyocyte injury
[J]. Tianjin Medical Journal, 2022, 50(12): 1264-1269.
|
[13] |
LIN Jie, WANG Wei-dong, OU Huo-hui, HE Wei, CHEN Jian-ping, MA Jing, ZUO Hai-bo, LIU Qing-bo.
The inhibitory effect of CLEC5A on cell proliferation and metastasis in intrahepatic
cholangiocarcinoma
[J]. Tianjin Medical Journal, 2021, 49(7): 678-682.
|
[14] |
ZHANG Ni, JIAN Jiu-ying, WANG Xiao-xiao, YU Ting, CHEN Si-yu, GUO Bing, LIU Li-rong .
Study on the correlation between histone methyltransferase 2 and cisplatin-induced
inflammation in chronic kidney disease
[J]. Tianjin Medical Journal, 2021, 49(10): 1048-1052.
|
[15] |
WEI Jin, YU Ling, TAN Hong-yu△.
The effect of perioperative anesthesia management on alanine aminotransferase recovery in
patients with liver cancer
[J]. Tianjin Medical Journal, 2020, 48(7): 650-653.
|